Few conversations are more frustrating for a physician than recommending the best course of action or treatment and hearing a patient say no. Knowing how to respond when patients refuse treatment is an important part of navigating these challenging conversations.

Realistically, physicians have two important responsibilities to balance: recommending appropriate care and respecting the patient’s role in decisions about their own treatment. The American Medical Association (AMA) Code of Medical Ethics describes informed consent as fundamental in ethics and law and states patients should receive the information they need to make well-considered decisions about care.

The goal is not to pressure the patient into agreement. It is to understand the refusal, communicate clearly, confirm the decision is informed and document the conversation appropriately.

Start by understanding why the patient is refusing treatment

Before repeating the medical recommendation, find out the reason behind the refusal.

The issue may be fear of side effects, cost, a previous healthcare experience, misinformation, distrust, recovery time, family or work obligations, cultural or personal values or a misunderstanding of the diagnosis itself. AMA ethics commentary recommends identifying underlying reasons for refusal that might be addressed through additional conversation and support.

Ask what is driving the decision

Open-ended questions can reveal concerns a yes-or-no question might miss:

• “What concerns you most about this treatment?”
• “Is there something about the recommendation that doesn’t feel acceptable to you?”
• “What would you need to understand better before making a decision?”

Remember: Refusal does not necessarily mean a patient is irrational or unwilling to engage. Sometimes the patient is not rejecting the clinical goal; they may be objecting to the timing, cost, route of administration, hospitalization, anticipated side effects or another practical burden.

Identifying that distinction can turn a standoff into a discussion about alternatives.

Confirm the decision is informed

Patient refusal of treatment should receive the same attention to informed decision-making as patient consent.

AMA guidance calls on physicians to assess the patient’s ability to understand relevant information and the implications of alternatives and to explain the diagnosis, purpose of the recommended intervention and the burdens, risks and expected benefits of available options—including forgoing treatment.

In practical terms, the patient should understand:

• what condition or concern is being addressed;
• what you recommend and why;
• the expected benefits and relevant risks or burdens;
• reasonable alternatives; and
• the potential consequences of declining or delaying treatment.

Use plain language and check understanding

A dense recitation of clinical facts does not necessarily produce an informed decision. Break complex information into manageable pieces and focus on what matters to the decision at hand.

Instead of finishing with “Do you understand?” consider teach-back:

“I want to make sure I explained the options clearly. Can you tell me how you understand the risks of choosing not to proceed?”

AHRQ describes teach-back as a way to confirm information was explained clearly by asking the patient to describe it in their own words. Keep in mind this technique is meant to check the clinician’s communication—not test the patient.

Consider decision-making capacity when appropriate

A patient can make a choice you believe carries substantial risk and still have decision-making capacity. Disagreement with your recommendation is not, by itself, evidence  the patient cannot decide.

At a high level, medical decision-making capacity generally involves the ability to understand relevant information, appreciate how it applies to one’s situation, reason about the available options and communicate a choice. Capacity is also specific to the decision being made rather than a single global judgment about the patient.

If there is a clinical reason to question capacity, a more structured assessment may be appropriate. Depending on the circumstances, additional support might involve another clinician, psychiatry, ethics, risk management or an appropriate surrogate decision maker.

The details can vary with the situation, applicable law and institutional policy, so a general article should not substitute for formal capacity procedures.

Use shared decision-making instead of turning the encounter into a standoff

Shared decision-making does not require physicians to become neutral about what they believe is medically appropriate.

AHRQ’s SHARE Approach describes shared decision-making as a five-step process that includes inviting patient participation, comparing options, assessing patient values and preferences, reaching a decision and evaluating that decision. Its emphasis is on meaningful dialogue about evidence, benefits, harms, risks and what matters most to the patient.

Ask about the patient’s goals, fears, responsibilities, tolerance for risk and concerns about treatment burden. These conversations can help clarify whether the disagreement concerns the medical evidence, the patient’s priorities or both.

Then make your clinical recommendation clear.

“Based on what we know, I recommend treatment A because it offers the best chance of preventing X. I understand you’re concerned about Y, so let’s talk through that concern and the alternatives.”

Shared decision-making does not require presenting every conceivable option as equally appropriate. You can explain reasonable alternatives while still identifying the approach you recommend based on your clinical judgment.

It also does not require agreement. A thoughtful decision-making process can still occur when a patient ultimately chooses differently than you recommend.

Respect patient autonomy without abandoning clinical judgment

Respecting autonomy does not mean simply agreeing with every patient decision. AMA ethics commentary recognizes physicians must balance patient preferences with evidence-based care and applicable professional and legal boundaries.

You can respect a patient’s decision while stating plainly what you recommend, why you recommend it and what risks you believe the patient is accepting.

When clinically appropriate, treatment refusal also does not need to end the physician-patient relationship. You may still be able to provide other appropriate care, monitor the condition, offer acceptable alternatives or revisit the decision later.

Language matters. In the medical record and the conversation itself, neutral descriptions such as “declined recommended treatment,” “chose not to proceed” or “did not consent to the proposed intervention” are generally more useful than characterizing a patient as defiant or disobedient.

What should physicians document when a patient refuses treatment?

Documentation should capture the clinical conversation—not merely the fact that the patient said no.

The AMA Code directs physicians to document the informed-consent conversation and the patient’s or surrogate’s decision in the medical record. Risk management guidance similarly treats informed refusal as a process that should be reflected in the record.

Depending on the encounter, relevant documentation may include:

• the diagnosis or clinical concern;
• the recommended treatment or intervention and why it was recommended;
• material benefits, risks and burdens discussed;
• reasonable alternatives;
• potential consequences of declining or delaying treatment;
• questions or concerns raised by the patient;
• the patient’s stated decision and, when relevant, reason for it;
• comprehension checks such as teach-back;
• capacity concerns or consultations, when applicable; and
• the follow-up plan, return precautions or opportunities to reconsider.

Avoid relying on boilerplate language that suggests a conversation occurred when it did not.

A signature is not the entire informed-refusal process

Some organizations or circumstances may call for an informed-refusal form. But a signature alone does not establish the patient received, understood and considered the relevant information.

MedPro’s risk management guidance, for example, states an informed consent or refusal form documents only one phase of the process and the patient’s signature alone does not make the consent or refusal valid.

Documentation requirements and informed-refusal processes can vary by organization, state and clinical setting. Physicians should follow applicable laws, institutional policies and risk management guidance.

What if the patient refuses treatment that may prevent serious harm?

Higher-stakes refusals make clear communication especially important.

Be specific about what you are concerned may happen, how serious the potential harm is and whether delaying care could change the patient’s options or prognosis. Keep the explanation factual rather than using fear as a coercive tactic.

When the circumstances warrant additional support, institutional resources may include ethics consultation, risk management, specialty input, surrogate decision-making processes or emergency protocols.

Emergencies can involve different consent considerations. AMA guidance states that when an urgent decision is required, the patient cannot participate and no surrogate is available, physicians may initiate necessary treatment without prior informed consent and address ongoing consent as soon as possible.

Common communication mistakes during treatment-refusal conversations

Difficult conversations can become even harder when frustration drives the interaction. Avoid:

• treating refusal as a personal challenge;
• assuming disagreement proves the patient did not understand;
• overwhelming the patient with jargon;
• repeating the same argument without exploring the underlying concern;
• failing to discuss reasonable alternatives;
• documenting only “patient refused”; or
• allowing urgency to become coercion.

Treatment refusal does not have to end the conversation

A patient’s initial “no” may be the final decision—or it may be one point in an ongoing clinical relationship.

The patient may need additional time, seek another opinion, return with questions, reconsider as circumstances change or choose another medically appropriate option. AHRQ’s shared decision-making framework explicitly includes evaluating and revisiting decisions as part of the process.

Your responsibility is to make the recommendation clear, understand the patient’s concerns, support an informed and voluntary decision and accurately document what occurred.

For more strategies on navigating disagreement, communication and challenging encounters, read our managing difficult patient interactions guide or visit the Physician Resource Center at PracticeLink.com.

Note: This article is for educational purposes and is not legal advice. Laws, organizational policies and informed-refusal requirements vary by jurisdiction and clinical setting.